Parallel with the reduction of p-ERK1/2, p-STAT5, and MYC levels, SYK inhibition profoundly decreased clonogenic potential and induced differentiation in AML cell lines (Supplementary Fig. S1C–E). The gene discussed is STAT5A; the disease is acute myeloid leukemia.